CASE COMMUNICATION
IMAJ | volume 25
Journal 11, November 2023
pages: 760-762
Immediate Improvement after Thymoma Resection in a Young Refractory Myasthenia Gravis Patient: A Case Report
1 Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel
2 Department of Neurology, Mayo Clinic, Rochester, MN, USA
3 Department of Neurology, Rambam Health Care Campus, Haifa, Israel
4 Neuroimmunology Laboratory, Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
Summary
In the acute settings of generalized myasthenia gravis (MG) treatment options include plasma exchange (PLEX), intravenous immunoglobulin (IVIG), and pyridostigmines. A thymoma is associated with the disease in up to 20% of cases [1,2].
In cases where a thymoma is detected, surgical treatment to remove the tumor is recommended in certain age groups. At present, there are no clear guidelines regarding the optimal time to perform thymectomy after diagnosis of acute crisis or from the last treatment to thymectomy. Treatment is at the clinician's discretion.